In this study, we found that SLB-M treatment ameliorated liver fibrosis by reducing collagen deposition and restoring tissue integrity by promoting the Fxr to appropriately decrease conjugated BAs by promoting Slco1a1, Slco1b1, and Sult2a8 expression. The gene discussed is NR1H4; the disease is Hepatic fibrosis.